Cempra (CEMP) Worth a Look: Stock Up 6.1% - Analyst Blog
2013年10月1日 - 10:00PM
Zacks
Cempra, Inc. (CEMP) was a big mover last
session, as the company saw its shares increase more than 6% on the
day. The move came on the back of solid volume too, as far more
shares changed hands than in a normal session. This continues the
recent uptrend for this drug company as the stock is now up nearly
28% in the past one month time frame.
The company has seen 4 positive estimate revisions in the past few
weeks and its earnings consensus has moved up over the past two
months, suggesting that more solid trading could be ahead for CEMP.
So make sure to keep an eye on this stock going forward to see if
this recent jump can turn into more strength down the road.
Cempra currently has a Zacks Rank #2 (Buy) and its Earnings ESP is
0.00%.
Other bio-tech stocks worth considering include Jazz
Pharmaceuticals Public Limited Company (JAZZ),
Lannett Company, Inc. (LCI) and Apricus
Biosciences, Inc. (APRI). All these carry the same Zacks
Rank as Cempra.
Want the latest recommendations from Zacks Investment Research?
Today, you can download 7 Best Stocks for the Next 30 Days. Click
to get this free report >>
APPRICUS BIOSCI (APRI): Free Stock Analysis Report
CEMPRA INC (CEMP): Free Stock Analysis Report
JAZZ PHARMACEUT (JAZZ): Free Stock Analysis Report
LANNETT INC (LCI): Free Stock Analysis Report
To read this article on Zacks.com click here.
Zacks Investment Research
London Clubs (AMEX:LCI)
過去 株価チャート
から 6 2024 まで 7 2024
London Clubs (AMEX:LCI)
過去 株価チャート
から 7 2023 まで 7 2024
Real-Time news about Lannett CO (アメリカ証券取引所): 0 recent articles
その他のLondon Clubsニュース記事